Analysts Viewpoint SGMT stock rated a Buy by H.C. Wainwright Sagimet Biosciences Inc’s filing revealed that its President & CEO Happel David acquired Company’s shares for reported $63731.0 on Mar
Analysts Viewpoint Sagimet Biosciences Inc (SGMT) receives a Buy rating from H.C. Wainwright In a filing, Sagimet Biosciences Inc revealed its President & CEO Happel David acquired Company’s shares for reported $63731.0 on
Insiders Updates Sagimet Biosciences Inc (SGMT) receives an Outperform rating from Leerink Partners Sagimet Biosciences Inc’s filing revealed that its President & CEO Happel David acquired Company’s shares for reported $63731.0 on Mar